Living With Polymyalgia Rheumatica: Movement, Bone Health and Everyday Routines

The kettle is on, but the mug is still in the cupboard. That is the problem. Reaching up for it this morning felt like lifting the arm through wet cement, and rolling out of bed took two attempts and a small grunt. By lunchtime the shoulders have loosened, the hips too, and it is almost possible to forget. Almost. Then tomorrow arrives, and the cupboard is out of reach again.

That pattern, stiffness that owns the morning and loosens its grip by midday, is often what finally sends someone over fifty to their doctor. When the answer comes back as polymyalgia rheumatica, or PMR, the first reaction is usually relief that it has a name, followed quickly by a second question: what does living with polymyalgia rheumatica look like from here?

The honest answer is that it is a season, not a sentence, but a season that asks for attention to three things most of us neglect: how we move, how we protect our bones, and how we structure an ordinary day.

What is actually happening in the body with polymyalgia rheumatica?

Polymyalgia rheumatica is an inflammatory condition in which the immune system, for reasons that are still not fully understood, sets off inflammation around the shoulders, neck, upper arms and hips. The word breaks down neatly: poly means many, myalgia means muscle pain, and rheumatica points to the joints and connective tissue. Despite the name, the muscles themselves are not being damaged. Imaging studies show the trouble lives in the bursae, the small fluid-filled cushions around joints, and in the linings of the shoulder and hip joints.

That distinction matters. It explains why muscle strength is usually preserved even when a person cannot lift their arms above their head, and why blood tests for muscle damage tend to come back normal. What does rise is a pair of general inflammation markers: erythrocyte sedimentation rate (ESR), which measures how quickly red blood cells settle in a tube, and C-reactive protein (CRP), a protein the liver releases when inflammation is present. Both are typically elevated at diagnosis, according to the National Institute of Arthritis and Musculoskeletal and Skin Diseases, though a small number of people have PMR with near-normal readings.

Nobody knows exactly what lights the fuse. Genetics play some role, and the condition appears more often in people of Northern European ancestry. Some researchers suspect an infection or other environmental trigger, but no single culprit has been identified. What is clear is that PMR is a condition of later life: the Mayo Clinic notes it rarely appears before 50 and the average age at onset is about 70. Women are affected roughly two to three times as often as men.

The everyday translation is this: the pain is real, it is inflammatory, and it is not a sign of weak or wasting muscles. That reassurance alone helps many people move again.

Who is usually treated straight away, and who is asked to wait?

There is no single test that confirms PMR. Doctors assemble the picture from age, the pattern of stiffness, raised inflammation markers, and, importantly, the absence of another explanation. That last step is where waiting sometimes comes in.

Several conditions can wear a PMR costume. Rheumatoid arthritis in older adults can begin with shoulder and hip stiffness. An underactive thyroid can cause aches and fatigue. Certain cancers, infections and other inflammatory muscle diseases can raise ESR and CRP. Because the standard treatment for PMR is a corticosteroid, a medicine that broadly dampens inflammation, and because corticosteroids make almost any inflammatory problem feel temporarily better, starting one too early can blur the diagnosis. A clinician who suspects a mimic may therefore order additional bloodwork, an ultrasound of the shoulders, or a referral to a rheumatologist, a specialist in joint and autoimmune disease, before prescribing.

People who are usually treated promptly are those over 50 with the classic picture: new bilateral shoulder and hip girdle pain, morning stiffness lasting well over half an hour, raised markers, and no red flags for another disease. The NHS describes the response to corticosteroids as so characteristic that it becomes part of the diagnostic reasoning; if a person does not improve substantially within a couple of weeks, the diagnosis is revisited.

Who else is asked to wait, or at least to talk first? Anyone with poorly controlled diabetes, active infection, severe osteoporosis, or a history of significant problems on steroids will typically have a longer conversation about risks and monitoring before starting. None of this means treatment is withheld; it means the plan is tailored. The decision about when to begin, what to use and how closely to monitor always sits with the prescribing clinician, who can weigh the individual picture in a way no article can.

What do the first days and weeks of treatment usually look like?

Few conditions respond as visibly as PMR. The Mayo Clinic describes symptoms easing within two or three days of starting a corticosteroid, and many people report that the first morning after their first dose feels like a different body. Arms lift. Socks go on without a struggle. Some describe it as almost eerie.

That dramatic early response is a clinical signpost. Doctors expect a large improvement within one to two weeks; if it does not arrive, they look again for another cause. Blood tests are usually repeated in the first month to confirm that ESR and CRP are falling alongside the symptoms.

The following weeks are quieter but still active. Once the inflammation is controlled, the prescriber begins a gradual reduction of the medicine, a process called tapering. The aim is to find the lowest amount that keeps symptoms away, because the side effects of corticosteroids accumulate with both amount and duration. Tapering is stepwise and slow. The NHS notes that most people remain on treatment for one to two years, and Cleveland Clinic points out that some need longer, particularly if symptoms return during a reduction step.

Early on, the new routines start too. A baseline bone density scan (a DXA scan, a low-radiation X-ray that measures bone mineral content) is often arranged. Blood pressure and blood sugar get checked. Vitamin D and calcium intake are reviewed. Many people are also asked to note their symptoms in a simple diary so that any flare during tapering can be matched to a specific step.

By the end of the first month, the shape of the year ahead is usually visible: regular review appointments, planned reductions, and a body that feels far more like its old self than it did in that stiff, cupboard-out-of-reach morning.

Is polymyalgia rheumatica a lifelong condition?

For most people, no. PMR is unusual among rheumatic conditions in that it commonly runs its course and settles. The NHS describes it as a condition that often improves over one to two years with treatment, after which many people are able to come off medication entirely under their doctor’s supervision. Cleveland Clinic gives a similar range and notes that a minority need treatment for several years.

Think of it less like a chronic disease and more like a long, stubborn inflammatory episode. The immune system flares, the flare is suppressed while it burns itself out, and eventually it quiets. Nobody can predict the exact duration for an individual, which is why prescribers reduce medicine cautiously and by symptoms rather than by calendar.

Where the word lifelong does apply is to two aftereffects. The first is vigilance. Anyone who has had PMR remains at some risk of giant cell arteritis, a related inflammation of blood vessels that is discussed in its own section below, and should treat new headache or vision symptoms seriously for life. The second is bone health. Months or years on corticosteroids can leave a lasting deficit in bone density, and the habits built to protect the skeleton during treatment are worth keeping long after the medicine stops.

Some people also describe a subtler legacy: a heightened awareness of their body, an unwillingness to ignore a stiff morning, a new relationship with exercise. Whether that counts as a burden or a benefit probably depends on the person.

The takeaway for someone newly diagnosed is measured optimism. The evidence supports the expectation that this will end, while also making clear that the end date is set by the disease, not the patient or the doctor.

Can PMR come back after treatment?

Yes, and this is the part of the journey that catches people off guard. A relapse, meaning the return of PMR symptoms after they had been controlled, most often happens during tapering, when the amount of corticosteroid drops below what the still-active inflammation requires. Cleveland Clinic notes that relapses are common and may affect around half of people at some point during treatment.

A relapse rarely announces itself as dramatically as the original illness. More typically it creeps: the morning stiffness stretches from ten minutes back to forty, the shoulders ache on waking, a general heaviness returns. Some people notice fatigue or low mood a few days before the physical symptoms. Inflammation markers often, though not always, rise in step.

The response is not a return to square one. The prescriber usually adjusts the medicine back to the last level that kept symptoms controlled, holds there for a period, and resumes the taper more slowly. This is why symptom diaries and regular blood tests matter so much; they let the care team distinguish a genuine PMR flare from an unrelated ache, a viral illness, or a bout of ordinary osteoarthritis. Not every stiff morning is a relapse, and treating it as one prolongs steroid exposure unnecessarily.

For people who relapse repeatedly or who develop significant steroid side effects, rheumatologists may discuss adding a steroid-sparing medicine such as methotrexate, an immune-modulating drug originally used in higher amounts for other conditions. The NHS mentions this option for people struggling to reduce their steroid. Its role in PMR is supported by some trials but the evidence is modest, and the decision rests entirely with the treating team.

Relapse after complete withdrawal of treatment can also occur, sometimes many months later. It is treated in the same way, and it does not mean the first course failed.

Living with polymyalgia rheumatica means knowing about giant cell arteritis

Giant cell arteritis, or GCA, is inflammation of the medium and large arteries, most often those running through the temples and scalp and sometimes the aorta, the body’s main artery. It shares an age profile and an immune signature with PMR, and the two conditions overlap in a way that anyone living with polymyalgia rheumatica needs to understand.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases reports that roughly 10 to 20 percent of people with PMR also develop GCA, and that about half of people with GCA have symptoms of PMR. The reason GCA earns its own section is that inflamed arteries can narrow or block, and when the affected vessel feeds the eye, vision loss can follow and can be permanent. It is one of the few emergencies in rheumatology.

The signs are distinct from ordinary PMR symptoms. A new, persistent headache, often at the temple. Tenderness of the scalp, sometimes noticed when brushing hair. Pain in the jaw when chewing that eases at rest, known as jaw claudication. Blurred, doubled or suddenly lost vision, even briefly. Unexplained fever or a sharp return of fatigue while PMR is otherwise controlled. The Mayo Clinic lists these as reasons for urgent assessment, not a routine appointment.

GCA is treated with corticosteroids too, but at considerably higher levels and often with additional medicines, which is why the distinction matters and why prescribers do not simply assume that a PMR patient’s headache is nothing.

None of this should become a source of daily dread. The great majority of people with PMR never develop GCA. What the evidence asks for is a simple rule, taught once and remembered: headache, scalp tenderness, jaw pain or any vision change means same-day contact with a doctor or emergency service, no matter how well the PMR is going.

Polymyalgia rheumatica exercise: what types are actually recommended?

The instinct when shoulders and hips ache is to rest them. With PMR, that instinct is usually wrong. Rest does nothing to the underlying inflammation, which the medicine handles, and it accelerates the two things that most threaten long-term function: muscle loss and bone loss, both of which corticosteroids also promote. The Mayo Clinic and NHS both recommend regular, moderate exercise as part of PMR care.

Three categories do the heavy lifting. The first is weight-bearing aerobic activity: walking, stair climbing, dancing, low-impact aerobics. Anything that loads the skeleton against gravity signals bone to maintain its density, and anything that raises the heart rate helps counter the weight gain, blood pressure and blood sugar effects of steroids. The second is resistance training: lifting light weights, using resistance bands, or bodyweight moves such as sit-to-stand from a chair and wall push-ups. Muscle is the body’s natural brace for joints and its best insurance against falls. The third is mobility and balance work: gentle range-of-motion exercises for the shoulders and hips, and balance practice such as tai chi or standing on one leg while holding a counter.

Swimming and cycling are excellent for fitness and joint comfort but are not weight-bearing, so they should sit alongside, not replace, walking or standing exercise if bone protection is a goal.

What about intensity? The evidence base specific to PMR is thin; recommendations lean on general guidance for older adults and for people on long-term steroids. That guidance favors consistency over ambition: something most days, at an effort that allows conversation, progressed slowly. A physical therapist, a clinician trained in movement and rehabilitation, can tailor a program to shoulder and hip limitations and check that form protects rather than strains. Asking for a referral is reasonable at any stage of treatment.

Building a movement routine when mornings belong to stiffness

Advice to exercise is easy to give and hard to schedule when the first hour of every day is spent negotiating with your own shoulders. The practical solution most people arrive at is to stop fighting the morning and design around it.

Warmth helps. A hot shower, a heating pad across the shoulders, or simply a few minutes moving gently in bed, circling ankles, rolling shoulders, drawing knees up, can shorten the stiff window. Some people find that taking their medicine at the time their prescriber suggests, then allowing it to work before attempting the day’s first demanding task, changes the texture of the morning entirely. Timing questions belong to the prescriber, but the observation that the body has a daily rhythm is worth sharing with them.

Place the main exercise session in the afternoon or early evening, when joints are loosest and energy is often better. A brisk twenty-minute walk after lunch, a short resistance routine before dinner, a few balance drills while the kettle boils. Small, repeated, unremarkable.

Break tasks apart. Vacuuming the whole house in one go is a shoulder marathon; two rooms today and two tomorrow is a manageable set of repetitions. The same logic applies to gardening, shopping and cooking. This is sometimes called pacing, and it is not laziness; it is load management, the same principle athletes use.

Watch for the difference between the ache of inflammation and the ache of muscles that have worked. The first tends to be symmetric, worst on waking, and improves with movement. The second is localized to what you used, arrives a day later, and fades. Learning to tell them apart takes a few weeks and removes a great deal of anxiety.

Finally, keep a record. A line in a notebook, steps on a phone. Progress in PMR is measured in months, and memory is a poor historian.

PMR and bone health: why steroids and skeletons need a plan from day one

Of all the side effects of corticosteroids, bone loss is the quietest and the most consequential. The medicine reduces the activity of bone-building cells, increases the activity of bone-removing cells, lowers calcium absorption from the gut, and blunts the sex hormones that normally protect the skeleton. The result is osteoporosis, a condition in which bones become porous and fracture easily, and it develops fastest in the first months of treatment.

The population most likely to have PMR, people in their sixties and seventies, and disproportionately women past menopause, is already the population at highest baseline fracture risk. Add a year or two of steroids and the arithmetic becomes concerning. This is why the NHS advises that people on long-term corticosteroids are usually offered calcium and vitamin D and may be prescribed a bone-protecting medicine, and why a DXA scan is commonly arranged at or near the start of treatment.

Calcium is the mineral that gives bone its hardness; vitamin D is the hormone-like nutrient that allows the gut to absorb calcium in the first place. The NIH Office of Dietary Supplements sets out recommended daily intakes for adults over 50 and lists food sources: dairy, fortified plant milks, canned fish with soft bones, leafy greens, tofu set with calcium. Whether diet alone is enough, and whether supplements are needed, is a conversation for the care team, who can check blood levels and account for other medicines.

Bisphosphonates are the class of medicine most often used to slow bone loss on steroids. They work by attaching to bone surfaces and reducing the activity of bone-removing cells. Their use is guided by fracture risk, scan results, age and expected duration of treatment, and is decided by the prescriber.

What the individual controls is the rest: weight-bearing movement, resistance training, not smoking, moderating alcohol, and making the home safer against falls, because the fracture that matters is the one that never happens.

Corticosteroid side effects and the everyday habits that push back

Corticosteroids are effective in PMR precisely because they act everywhere, and that reach is what produces side effects. Not everyone experiences them, and they generally scale with amount and duration, which is the whole logic of tapering. Still, knowing what to watch for turns a passive patient into an active one. The table below summarizes the common effects listed by the Mayo Clinic and NHS alongside habits that the evidence supports and that sit within a person’s own control. It is not a substitute for monitoring by the care team.

Possible effect	Why it happens	Everyday habits that help	What the care team monitors
Bone thinning	Reduced bone formation, increased breakdown, less calcium absorbed	Weight-bearing and resistance exercise; adequate calcium and vitamin D; no smoking	DXA scan; fracture risk assessment; bone-protecting medicine if indicated
Weight gain and appetite increase	Steroids alter appetite signals and fat distribution	Regular meals built around protein and fiber; daily walking; planning snacks	Weight and waist at reviews
Raised blood sugar	Steroids increase glucose production and reduce insulin sensitivity	Limiting sugary drinks and refined carbohydrate; activity after meals	Blood glucose or HbA1c tests
Raised blood pressure and fluid retention	Salt and water retention	Lower-sodium cooking; movement; moderating alcohol	Blood pressure at each visit
Sleep disturbance and mood changes	Direct effects on the brain and stress hormone rhythm	Consistent sleep schedule; daylight exposure; telling someone how you feel	Asking about mood and sleep; timing of medicine
Thinning skin, easy bruising	Reduced collagen production	Sun protection; gentle skin care; care with sharp edges	Skin checks
Infection risk	Dampened immune response	Hand hygiene; staying current with vaccines as advised	Vaccination review; prompt assessment of fevers
Eye changes (cataract, raised pressure)	Long-term steroid exposure to lens and eye fluid	Reporting any vision change promptly	Periodic eye examination

One safety point deserves plain statement. Long-term corticosteroids suppress the body’s own production of cortisol, so the medicine should never be stopped abruptly or skipped for days; the taper is medical, not optional. Many services provide a steroid alert card to carry so that emergency staff know.

Everyday routines that make living with polymyalgia rheumatica easier

Medicine controls the inflammation. Routine controls almost everything else. The people who describe living with polymyalgia rheumatica as manageable rather than miserable tend to have built small, boring structures around the condition.

Sleep. Corticosteroids can make sleep shallow and mornings early, and poor sleep amplifies pain perception. A fixed bedtime and wake time, a dark and cool room, and a hard stop on screens an hour before bed are unglamorous but supported by general sleep evidence. If the medicine itself seems to be the problem, the timing of the dose is a legitimate topic for the prescriber.

Food. There is no diet that treats PMR, and claims otherwise should be treated with skepticism. What the evidence does support is eating in a way that counters steroid effects: protein at each meal to protect muscle, plenty of vegetables and whole grains for fiber and blood sugar stability, calcium-rich foods for bone, and a light hand with salt and added sugar. Alcohol within moderate limits, both for bone and for blood pressure.

Energy. Fatigue is part of PMR and is not fully relieved by treatment in everyone. Planning the week so that demanding days are followed by lighter ones, and building in a short rest rather than pushing to collapse, keeps activity levels higher overall.

Paperwork. Keep a single folder or phone note with current medicine details, the taper plan as written by the prescriber, blood test dates and results, and the symptom diary. Reviews go faster and decisions get better when the history is on the table.

Relationships. An invisible illness that improves by lunchtime is easy for others to underestimate. A short, honest explanation to family and colleagues, that mornings are hard and afternoons are fine, and that this is temporary but real, prevents a great deal of quiet resentment on both sides.

Can you recover from PMR without treatment?

This question comes up often, sometimes from people wary of steroids and sometimes from those who feel their symptoms are mild enough to endure. The honest answer has two parts.

First, the natural history. PMR is understood to be self-limiting in many people, meaning that the inflammation eventually subsides on its own, often over a period of a year or more. In that narrow sense, recovery without treatment is possible. Historical descriptions from before corticosteroids were available document exactly this course.

Second, and more important, what those years look like. Untreated PMR produces daily pain, prolonged morning stiffness, disturbed sleep, fatigue, and progressive loss of function. People stop lifting, stop walking, stop leaving the house; muscle wastes from disuse and the fall risk climbs. The inflammation also carries the associated risk of giant cell arteritis, and the NIAMS is explicit that GCA left untreated can cause permanent vision loss. There is no reliable way to predict, at the outset, who will settle quickly and who will suffer for years.

For these reasons, mainstream guidance from the NHS, Mayo Clinic and Cleveland Clinic recommends treating PMR with corticosteroids rather than waiting it out. The medicine does not shorten the underlying disease; it removes the suffering and disability while the disease runs its course, and it is tapered as the disease fades.

Someone who is hesitant about steroids has every right to raise that hesitation. Concerns about bone, weight, sleep and blood sugar are legitimate and addressable, and the monitoring described elsewhere in this article exists precisely to manage them. What the evidence does not support is the idea that enduring untreated PMR is the safer path. The conversation belongs with the prescribing clinician, who can lay out the individual risks on both sides.

What people often get wrong about PMR

A condition that is common, dramatic in onset and quick to respond to treatment attracts more than its share of folklore. A few corrections, each grounded in mainstream evidence.

“It’s a muscle disease, so I should rest my muscles.” Imaging places the inflammation in the bursae and joint linings, not in muscle fibers, and muscle strength is typically normal. Resting accelerates the muscle and bone loss that steroids already encourage. Movement, not rest, is the recommended posture.

“Once I feel better I can stop the medicine.” Feeling better within days is expected and is not the same as the disease being over. Stopping abruptly risks a rebound flare and, after long-term use, a dangerous shortfall of the body’s own cortisol. Reductions are planned by the prescriber in steps.

“PMR is just arthritis with a fancy name.” Osteoarthritis is mechanical wear, is usually asymmetric and does not raise inflammation markers. PMR is systemic inflammation with a distinct pattern and treatment. The two can coexist, which is one reason a persistent knee ache during tapering is not automatically a relapse.

“A headache is just a headache.” In someone with PMR, a new persistent headache, scalp tenderness or jaw pain on chewing is the recognized warning pattern for giant cell arteritis and warrants same-day assessment. This is the one myth with the power to cost eyesight.

“An anti-inflammatory diet or supplement will treat it.” No dietary pattern or supplement has been shown to control PMR inflammation. Eating well protects against steroid side effects, which is valuable, but it is not treatment.

“It runs in families and I’ll pass it on.” Genetic factors contribute modestly, but PMR is not inherited in any predictable way and is not something a person gives to their children.

“Relapse means I did something wrong.” Relapses during tapering are common and reflect disease activity, not patient behavior.

Questions to ask your care team

Appointments are short and PMR raises long questions. Arriving with a written list changes the quality of the conversation. These are the ones that experienced patients say they wish they had asked earlier.

• How confident are you in the diagnosis, and what else was considered and ruled out?
• What does my written taper plan look like, and what should I do if symptoms return between appointments?
• How often will my blood tests be repeated, and which numbers are we watching?
• Have I had, or should I have, a bone density scan? What did it show, and does it change my plan?
• Are calcium and vitamin D supplements appropriate for me, and should a bone-protecting medicine be considered?
• What time of day should I take my medicine, and can timing help with sleep or morning stiffness?
• Which of my other medicines interact with corticosteroids, and does anything need adjusting?
• What are the specific warning signs of giant cell arteritis I should know, and who do I contact if they appear outside office hours?
• Should I carry a steroid alert card, and what should I do if I am unwell and cannot take my medicine?
• Are my vaccinations up to date, and are there any I should have or avoid while on treatment?
• Can I be referred to a physical therapist to design an exercise program around my shoulders and hips?
• If I struggle to reduce the steroid, what are the options, and what does the evidence say about them?
• How will we decide that treatment is finished, and what follow-up happens afterward?

Not every question needs answering at the first visit. Some belong at the three-month review, others at the point where tapering stalls. What matters is that the questions are yours, the answers are written down, and the plan is one you understand well enough to follow when the clinic door is closed. The decisions remain with the treating team; the understanding is yours to insist on.

When to call your doctor

Most of living with polymyalgia rheumatica is routine: planned reductions, planned blood tests, planned reviews. A short list of situations breaks that routine and should prompt contact the same day, or emergency care where indicated.

Seek urgent, same-day care for any of the following, because they may signal giant cell arteritis: a new or unusually persistent headache, especially at the temples; tenderness of the scalp; pain in the jaw when chewing that eases at rest; any change in vision, including blurring, double vision, a curtain across part of the visual field, or brief loss of sight in one eye, even if it resolves. The NIAMS and Mayo Clinic are clear that prompt treatment in GCA protects eyesight and that delay can make vision loss permanent.

Contact your care team promptly if PMR symptoms return or worsen during or after tapering; if you develop a fever, persistent cough, painful urination or another sign of infection, since corticosteroids blunt the body’s response; if you are vomiting or otherwise unable to take your medicine, because the body’s own cortisol production is suppressed during long-term treatment and a sudden gap can cause weakness, dizziness, low blood pressure or collapse; if you notice unusual thirst, frequent urination or blurred vision that could indicate raised blood sugar; if you experience marked mood change, agitation or low mood; or if you fall or suspect a fracture, however minor the impact seemed.

Mention at your next routine visit new bruising, swelling of the ankles, indigestion, or difficulty sleeping. These are common and manageable but should be on the record.

If in doubt, call. Clinicians who manage PMR would far rather hear about a headache that turns out to be nothing than learn about one that was something after the fact.

Frequently asked questions

Can you recover from PMR without treatment?

PMR often settles on its own over a year or more, so recovery without treatment is possible in the strict sense, but mainstream guidance recommends against waiting it out. Untreated PMR causes prolonged pain, disability, muscle loss from disuse, and carries the associated risk of giant cell arteritis and its threat to vision. Corticosteroids remove the suffering while the disease runs its course. Any hesitation about treatment should be discussed with the prescribing clinician.

Is polymyalgia rheumatica lifelong?

Usually not. The NHS and Cleveland Clinic describe most people completing treatment within one to two years, with a minority needing longer. What does last is the need to stay alert to symptoms of giant cell arteritis, such as new headache or vision change, and the value of protecting bone density after months on corticosteroids. Many people describe PMR as a long season rather than a permanent condition.

Can PMR come back after treatment?

Yes. Relapses most often occur during tapering, when the corticosteroid drops below what the still-active inflammation requires, and Cleveland Clinic notes they may affect around half of people at some point. Symptoms can also return months after treatment has ended. Relapse is managed by adjusting medicine under the prescriber’s guidance and resuming a slower taper; it does not mean the original course failed or that anything was done wrong.

What types of exercise are recommended for people with polymyalgia rheumatica?

Weight-bearing aerobic activity such as walking, resistance training with bands or light weights, and mobility and balance work such as tai chi form the recommended core. Together they counter the muscle and bone loss that both PMR inactivity and corticosteroids promote. Swimming and cycling are good for fitness but not weight-bearing, so they work best alongside standing exercise. A physical therapist can tailor a program around shoulder and hip limits.

How long does PMR treatment usually last?

Most people remain on a slowly reducing corticosteroid for one to two years, according to the NHS, and Cleveland Clinic notes that some need treatment for several years, particularly if symptoms return during reductions. The duration is set by the disease, not by a schedule; prescribers lower the medicine in steps based on symptoms and inflammation markers. Nobody can promise an individual end date at the outset.

What is the link between PMR and giant cell arteritis?

The two conditions share an age profile and immune features, and the NIAMS reports that roughly 10 to 20 percent of people with PMR develop giant cell arteritis, an inflammation of medium and large arteries. GCA can affect blood supply to the eye and cause permanent vision loss if not treated quickly. New persistent headache, scalp tenderness, jaw pain when chewing or any vision change in someone with PMR requires same-day medical assessment.

How can I protect my bones while taking steroids for PMR?

Bone protection combines things you control with things your care team arranges. Weight-bearing and resistance exercise most days, adequate calcium and vitamin D from food or supplements as advised, not smoking, and moderating alcohol all help. The care team typically arranges a bone density scan, assesses fracture risk, and may prescribe a bone-protecting medicine. Because bone loss is fastest early in treatment, these steps matter from the beginning.

Why does PMR stiffness feel worse in the morning?

Inflammatory conditions follow a daily rhythm in which inflammatory chemicals peak in the early hours, and lying still overnight allows inflamed joint linings and bursae to stiffen. Movement, warmth and the day’s medicine gradually loosen them. Stiffness lasting well over half an hour on waking is one of the features doctors use to distinguish PMR from ordinary wear-and-tear arthritis, which tends to stiffen briefly and ease within minutes.

Does diet make a difference in PMR?

No diet has been shown to control PMR inflammation, so claims that a particular eating pattern treats the condition are not supported. Diet does matter for managing corticosteroid side effects: protein at each meal protects muscle, fiber and whole grains steady blood sugar, calcium-rich foods support bone, and limiting salt and added sugar helps blood pressure and weight. Eating well is a companion to treatment, not a replacement for it.

What should I do if I cannot take my PMR medicine because I am unwell?

Contact your care team the same day. Long-term corticosteroids suppress the body’s own cortisol production, so a sudden gap can cause weakness, dizziness, low blood pressure or collapse, and illness itself increases the body’s need for cortisol. Clinicians have clear protocols for these situations. Many services issue a steroid alert card to carry so that emergency staff are aware; ask about one if you have not been offered it.

References

• NHS: Polymyalgia rheumatica
• MedlinePlus: Polymyalgia rheumatica

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.